These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 15662155)
1. Adolescent weight loss during treatment with olanzapine. Cohen JA; Perel JM J Child Adolesc Psychopharmacol; 2004; 14(4):617-20. PubMed ID: 15662155 [TBL] [Abstract][Full Text] [Related]
2. Obsessive-compulsive symptoms with olanzapine. Alevizos B; Papageorgiou C; Christodoulou GN Int J Neuropsychopharmacol; 2004 Sep; 7(3):375-7. PubMed ID: 15231024 [TBL] [Abstract][Full Text] [Related]
3. Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial. Chawla B; Luxton-Andrew H Hum Psychopharmacol; 2008 Apr; 23(3):211-6. PubMed ID: 18219624 [TBL] [Abstract][Full Text] [Related]
4. The antidepressant effects of risperidone and olanzapine in bipolar disorder. McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475 [TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine. Graham KA; Gu H; Lieberman JA; Harp JB; Perkins DO Am J Psychiatry; 2005 Sep; 162(9):1744-6. PubMed ID: 16135638 [TBL] [Abstract][Full Text] [Related]
7. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. Saddichha S; Ameen S; Akhtar S J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337 [TBL] [Abstract][Full Text] [Related]
8. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain? Vieweg WV; Sood AB; Pandurangi A; Silverman JJ Acta Psychiatr Scand; 2005 Mar; 111(3):177-84. PubMed ID: 15701101 [TBL] [Abstract][Full Text] [Related]
9. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study. Stephens RJ; Bassel C; Sandor P J Child Adolesc Psychopharmacol; 2004; 14(2):255-66. PubMed ID: 15319022 [TBL] [Abstract][Full Text] [Related]
11. Metformin for weight loss in pediatric patients taking psychotropic drugs. Morrison JA; Cottingham EM; Barton BA Am J Psychiatry; 2002 Apr; 159(4):655-7. PubMed ID: 11925306 [TBL] [Abstract][Full Text] [Related]
12. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Cooper GD; Harrold JA; Halford JC; Goudie AJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447 [TBL] [Abstract][Full Text] [Related]
13. Open-label olanzapine treatment in five preadolescent children. Krishnamoorthy J; King BH J Child Adolesc Psychopharmacol; 1998; 8(2):107-13. PubMed ID: 9730076 [TBL] [Abstract][Full Text] [Related]
14. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179 [TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-associated weight gain. Gentile S Ann Pharmacother; 2004 May; 38(5):903-4. PubMed ID: 14996995 [No Abstract] [Full Text] [Related]
17. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients. Park YM; Cho JH; Kang SG; Choi JE; Lee SH; Kim L; Lee HJ J Clin Pharm Ther; 2008 Feb; 33(1):55-60. PubMed ID: 18211617 [TBL] [Abstract][Full Text] [Related]
18. Olanzapine-induced obsessive-compulsive disorder. Mottard JP; de la Sablonnière JF Am J Psychiatry; 1999 May; 156(5):799-800. PubMed ID: 10327925 [No Abstract] [Full Text] [Related]